30-Mar-16 Major Malaysia pharma company Pharmaniaga Bhd expects its business in Indonesia to be profitable this year with a 1-2% growth in terms of contribution to its overall revenue. “In Indonesia currently, we have got common products manufactured there and we got high-end generic products in Malaysia, like cardiovascular products, that we can easily export,” managing director Datuk Farshila Emran said. [image: Pharmaniaga Bhd]

30-Mar-16 Chinese hospital operator Zhongmei Healthcare Group, in which the Carlyle Group made a USD64 mn investment in Jan-16, is seeking an initial public offering in Hong Kong. Zhongmei owns three specialty hospitals and manages three hospitals in China. [Image: The Carlyle Group]

29-Mar-16 Malaysia's TMC Life Sciences Bhd is building a new hospital in Iskandar, and expanding its Kota Damansara hospital for a combined RM1.5 bn (USD384 mn). By 2019, beds at Kota Damansara will increase to 600. Iskandariah Hospital will provide 500 beds, which will also cater to patients from Singapore and Indonesia. TMC is targeting 25% revenue contribution from medical tourism by 2020. [image: TMC Life Sciences Bhd]

28-Mar-16 Hospital operator PT Siloam International Hospitals, part of the Lippo Group, will set up 13 new hospital chains across Indonesia within two years. The plan will see Siloam's full-service hospitals increase to 33 from 20 at present. Each hospital is estimated to consume an average investment of USD8 mn. [image: ANTARA / Sahrul Manda Tikupadang]

23-Mar-16 Foreign investors have turned their attention to multi-million-dollar projects in Myanmar’s healthcare industry after being shut out for years. Rising incomes, a budding middle class and opportunities in a market that currently relies on overseas medical care are enticing foreign companies to the country. Entrants include Malaysia's Parkway, Thonburi and Bumrungrad from Thailand, and Indonesia's Lippo Group. [image: Zarni Phyo / The Myanmar Times]